150 related articles for article (PubMed ID: 2837679)
1. Incidence of cytomegalovirus infections in renal transplant patients treated with conventional or cyclosporin therapy.
Guerin C; Pozzetto B; Genin C; Berthoux FC; Gaudin OG
Nephrol Dial Transplant; 1988; 3(1):77-80. PubMed ID: 2837679
[TBL] [Abstract][Full Text] [Related]
2. Decreased Cytomegalovirus infection after antilymphocyte therapy in sirolimus-treated renal transplant patients.
Ozaki KS; Câmara NO; Galante NZ; Camargo LF; Pacheco-Silva A
Int Immunopharmacol; 2005 Jan; 5(1):103-6. PubMed ID: 15589467
[TBL] [Abstract][Full Text] [Related]
3. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
[TBL] [Abstract][Full Text] [Related]
6. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus infection following renal transplantation in patients administered low-dose rituximab induction therapy.
Nishida H; Ishida H; Tanaka T; Amano H; Omoto K; Shirakawa H; Shimizu T; Iida S; Toki D; Yamaguchi Y; Tanabe K
Transpl Int; 2009 Oct; 22(10):961-9. PubMed ID: 19619177
[TBL] [Abstract][Full Text] [Related]
8. [Antilymphocytic sera versus azathioprine, combined with cyclosporin and steroids, in liver transplant. Comparison of the results at the intensive care unit and 2 years' follow-up].
Cisneros Alonso C; Díaz Castellanos MA; Montero Castilló A; Moreno González E; Calleja González J; Gómez Gutiérrez M; Sánchez-Izquierdo Riera JA; García Fuentes C
Rev Clin Esp; 1990 Feb; 186(2):68-73. PubMed ID: 2330440
[TBL] [Abstract][Full Text] [Related]
9. Role of immunosuppressive regimen on the incidence and characteristics of cytomegalovirus infection in heart transplantation: a single-center experience with preemptive therapy.
De Santo LS; Romano G; Mastroianni C; Roberta C; Della Corte A; Amarelli C; Maiello C; Giannolo B; Marra C; Ragone E; Grimaldi M; Utili R; Scardone M; Cotrufo M
Transplant Proc; 2005; 37(6):2684-7. PubMed ID: 16182784
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A in renal transplantation: a prospective randomized trial.
Ferguson RM; Rynasiewicz JJ; Sutherland DE; Simmons RL; Najarian JS
Surgery; 1982 Aug; 92(2):175-82. PubMed ID: 6285533
[TBL] [Abstract][Full Text] [Related]
11. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
Cantarovich M; Latter DA; Loertscher R
Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
[TBL] [Abstract][Full Text] [Related]
12. Nursing implications of immunosuppression in transplantation.
Shaefer M; Williams L
Nurs Clin North Am; 1991 Jun; 26(2):291-314. PubMed ID: 1904575
[TBL] [Abstract][Full Text] [Related]
13. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial.
Eason JD; Loss GE; Blazek J; Nair S; Mason AL
Liver Transpl; 2001 Aug; 7(8):693-7. PubMed ID: 11510013
[TBL] [Abstract][Full Text] [Related]
14. CMV in kidney transplantation: a single center experience over 22 years.
Nashan B; Lück R; Kliem V; Brunkhorst R; Schlitt HJ; Klempnauer J
Clin Transpl; 1999; ():181-8. PubMed ID: 11038636
[TBL] [Abstract][Full Text] [Related]
15. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
[TBL] [Abstract][Full Text] [Related]
17. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus prophylaxis in pediatric renal transplant recipients.
So S; Mayo C; McCullough C; Jendrisak M; Woodle S; Marsh W; Bailey T
Transplant Proc; 1993 Feb; 25(1 Pt 2):1414-5. PubMed ID: 8382865
[No Abstract] [Full Text] [Related]
19. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD
Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
[TBL] [Abstract][Full Text] [Related]
20. The problem of cytomegalovirus infection in renal allograft recipients.
Kurtz JB; Thompson JF; Ting A; Pinto A; Morris PJ
Q J Med; 1984; 53(211):341-9. PubMed ID: 6091169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
